News related to Amevive (Alefacept) and/or conditions it is approved for
T-Cell Subtypes Do Not Differentiate Erythrodermic Psoriasis, Dermatitis
Source: Medscape Dermatology Headlines [2015.03.18]
Although helper T-cell subtypes 1 (TH1) and 2 (TH2) differ between psoriasis and atopic dermatitis, they cannot discriminate between these diseases in their erythrodermic phases, researchers report.
Reuters Health Information
New antibody therapy dramatically improves psoriasis symptoms in clinical trial
Source: Immune System / Vaccines News From Medical News Today [2015.03.17]
Only a single treatment produced what researchers describe as 'rapid, substantial, and durable clinical improvement'A sample from one psoriasis patient shows thickening of the outer layer of...
Marshaling the body's own weapons against psoriasis
Source: Dermatology News From Medical News Today [2015.03.03]
Immunotherapy with natural signaling substance relieves skin conditionA three-character code brings relief to patients with psoriasis and sheds light on complex immunoregulation processes: IL-4...
First independent U.S. psoriasis registry to track drug safety and effectiveness
Source: Dermatology News From Medical News Today [2015.03.02]
People with psoriasis and their health care providers will have the opportunity to participate in research that aims to improve treatments and disease outcomes when the first independent U.S.
Source: MedicineNet Actinic Keratosis Specialty [2015.01.28]
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 1/28/2015 12:00:00 AM
Psoriasis Pictures Slideshow: See Moderate to Severe Forms of this Common Skin Condition
Source: MedicineNet Actinic Keratosis Specialty [2015.01.15]
Title: Psoriasis Pictures Slideshow: See Moderate to Severe Forms of this Common Skin Condition
Created: 2/3/2015 12:00:00 AM
Last Editorial Review: 1/15/2015 12:00:00 AM
Source: MedicineNet alefacept Specialty [2014.05.20]
Title: Scalp Psoriasis
Category: Diseases and Conditions
Created: 7/24/2012 3:21:00 PM
Last Editorial Review: 5/20/2014 12:00:00 AM
Psoriasis Drug May Help Treat Type 1 Diabetes: Report
Source: MedicineNet alefacept Specialty [2013.09.24]
Title: Psoriasis Drug May Help Treat Type 1 Diabetes: Report
Category: Health News
Created: 9/23/2013 7:35:00 PM
Last Editorial Review: 9/24/2013 12:00:00 AM
Psoriasis Quiz: Test Your Medical IQ
Source: MedicineNet alefacept Specialty [2011.08.16]
Title: Psoriasis Quiz: Test Your Medical IQ
Category: MedicineNet Quiz
Created: 4/21/2011 3:23:00 PM
Last Editorial Review: 8/16/2011 1:27:34 PM
Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.
Remsima (infliximab) accepted for restricted use in NHS Scotland by the Scottish Medicines Consortium
Source: Arthritis / Rheumatology News From Medical News Today [2015.03.11]
Patients in Scotland suffering from inflammatory conditions including rheumatoid arthritis (RA), Crohn's Disease (CD), ulcerative colitis (UC), and psoriasis will now have access to a new wave of...
"Worm pill" could ease autoimmune disease symptoms
Source: Lupus News From Medical News Today [2014.08.12]
Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid...